Perioperative transfusion and long-term mortality after cardiac surgery: a meta-analysis

Kei Woldendorp1, Lucy Manuel2, Arpit Srivastava3

  • 1Department of Cardiothoracic Surgery, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia. kei.woldendorp@gmail.com.

Insights

Red blood transfusions after cardiac surgery are linked to worse long-term survival. Minimizing transfusions through strategies like preoperative optimization and blood conservation is recommended to improve patient outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Transfusion Medicine
  • Outcomes Research

Background:

  • Cardiac surgery frequently involves blood loss and transfusions, with debated impacts on long-term mortality.
  • This review examines perioperative blood transfusion outcomes in cardiac surgery patients.

Approach:

  • A systematic review and meta-analysis of 39 studies involving 180,074 patients.
  • Analysis included aggregate survival data to assess long-term mortality associated with transfusions.

Key Points:

  • 42.2% of patients received perioperative transfusions, associated with higher early mortality (OR 3.87).
  • Long-term mortality remained significantly higher for transfused patients (OR 2.01) up to 15 years post-surgery.
  • Findings held true across different cardiac procedures and after adjusting for confounding factors.

Conclusions:

  • Perioperative red blood cell transfusion is associated with reduced long-term survival in cardiac surgery patients.
  • Strategies to minimize transfusion necessity, including preoperative optimization and intraoperative blood conservation, are crucial.
  • Minimally invasive techniques and judicious transfusion practices should be employed to enhance patient survival.
Abstract